BioSpace News Archive

Business

Precigen Reports First Quarter 2022 Financial Results and Business Updates

Precigen, Inc. (Nasdaq: PGEN), a biopharmaceutical company specializing in the development of innovative gene and cell therapies to improve the lives of patients, today announced first quarter 2022 financial results and business updates.

May 9, 2022
·
10 min read
Business

Geron Corporation Reports First Quarter 2022 Financial Results

Geron Corporation, a late-stage clinical biopharmaceutical company developing a first-in-class telomerase inhibitor, imetelstat, to treat hematologic malignancies, reported financial results for the first quarter of 2022, including current and projected financial resources.

May 9, 2022
·
17 min read
Business

Nuvation Bio Reports First Quarter 2022 Financial Results and Provides Business Update

Nuvation Bio Inc. (NYSE: NUVB), a biopharmaceutical company tackling some of the greatest unmet needs in oncology by developing differentiated and novel therapeutic candidates, today reported its financial results for the first quarter ended March 31, 2022, and provided a business update.

May 9, 2022
·
9 min read
Business

Castle Biosciences Reports First Quarter 2022 Results

Castle Biosciences, Inc. (Nasdaq: CSTL), a company improving health through innovative tests that guide patient care, today announced its financial results for the first quarter ended March 31, 2022.

May 9, 2022
·
24 min read
Business

Establishment Labs Reports Record First Quarter 2022 Financial Results

Establishment Labs Holdings Inc. (NASDAQ: ESTA), a global medical technology company dedicated to improving women’s health and wellness, principally in breast aesthetics and reconstruction, today announced its financial results for the first quarter ended March 31, 2022.

May 9, 2022
·
11 min read
Business

Quantum-Si Reports First Quarter 2022 Financial Results

Quantum-Si Incorporated announced financial results for the first quarter ending March 31, 2022.

May 9, 2022
·
12 min read
Business

Verastem Oncology Reports First Quarter 2022 Financial Results and Highlights Recent Company Progress

Verastem Oncology (Nasdaq: VSTM), a biopharmaceutical company committed to advancing new medicines for patients with cancer, today reported financial results for the three months ended March 31, 2022 and highlighted recent progress.

May 9, 2022
·
15 min read
Business

Enanta Pharmaceuticals Reports Financial Results for its Fiscal Second Quarter Ended March 31, 2022 With Webcast and Conference Call Today at 4:30 p.m. ET

Enanta Pharmaceuticals, Inc. (NASDAQ:ENTA), a clinical-stage biotechnology company dedicated to creating small molecule drugs for viral infections and liver diseases, today reported financial results for its fiscal second quarter ended March 31, 2022.

May 9, 2022
·
12 min read
Business

Vicarious Surgical Reports First Quarter 2022 Financial Results

Vicarious Surgical Inc. (“Vicarious Surgical” or the “Company”) (NYSE: RBOT, RBOT WS), a next-generation robotics technology company seeking to improve patient outcomes as well as both the cost and efficiency of surgical procedures, today announced financial results for the quarter ended March 31, 2022.

May 9, 2022
·
10 min read
Business

Paragon 28 Reports First Quarter 2022 Financial Results and Increases 2022 Net Revenue Guidance

Paragon 28, Inc. reported financial results for the quarter ended March 31, 2022 and updated its 2022 revenue guidance.

May 9, 2022
·
11 min read